| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
34,850,000 |
| Market
Cap: |
9.17(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1389 - $0.368 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
278,643 |
| Total Buy Value |
$0 |
$0 |
$0 |
$610,243 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
0 |
599,209 |
1,097,868 |
1,140,781 |
| Total Sell Value |
$0 |
$97,534 |
$178,625 |
$257,300 |
| Total People Sold |
0 |
3 |
3 |
6 |
| Total Sell Transactions |
0 |
5 |
14 |
43 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lamond David |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
914,589 |
914,589 |
|
- |
|
| Vandevender Aaron |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,659 |
12,659 |
|
- |
|
| Epq Llc, Amtb Ps |
10% Owner |
– – • |
2020-06-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,394,948 |
|
- |
|
| Epq Llc, Amtb Ps |
10% Owner |
– – • |
2020-06-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,149,292 |
|
- |
|
| Mahmood Tahir Ph.d. |
Chief Executive OfficerOfficer |
• • – |
2020-06-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,600,000 |
|
- |
|
| Mrsny Randall Ph.d. |
Chief Scientific OfficerOffice |
• • – |
2020-06-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,600,000 |
|
- |
|
106 Records found
|
|
Page 5 of 5 |
|
|
